Latest Breaking News On - Executive chair richard douglas - Page 1 : comparemela.com

MaxCyte Inc - cell-engineering technology platform based in US state of Maryland - Non-Executive Chair Richard Douglas buys 80,000 shares at average USD4.32, worth USD345,480, on Wednesday. Now has. | March 30, 2023

United statesTom waiteRichard douglasAlliance news ltdMaxcyte incAlliance newsExecutive chair richard douglasAll rightsNc stock exchangePress releaseOw mxct us57777k1060